Varanah Ventures AG
Varanah Ventures AG develops early diagnostic medical devices that use AI to analyze large diagnostic data. It combines sensory inputs with machine learning to detect conditions such as COVID-19 infections, dementia, concussion, ADHD, and anxiety. Core technology includes AI processing, sensor data capture, and data analytics in the category of B2B medical devices, often integrating with clinical data workflows. Target customers are healthcare providers and clinics seeking early screening tools. The solution aims to scale across clinical settings and broaden diagnostic coverage with data-driven insights.
Varanah Ventures AG
Varanah Ventures AG develops early diagnostic medical devices that use AI to analyze large diagnostic data. It combines sensory inputs with machine learning to detect conditions such as COVID-19 infections, dementia, concussion, ADHD, and anxiety. Core technology includes AI processing, sensor data capture, and data analytics in the category of B2B medical devices, often integrating with clinical data workflows. Target customers are healthcare providers and clinics seeking early screening tools. The solution aims to scale across clinical settings and broaden diagnostic coverage with data-driven insights.